Edian
Edian.ai provides AI-powered decision support tooling for pharmaceutical and life sciences organizations, helping expert teams accelerate drug development while maintaining rigorous regulatory compliance. The platform supports clinical trial planning, regulatory intelligence, and cross-functional collaboration with GxP-aligned, 21 CFR Part 11-compliant systems that can be deployed within a customer's own environment. Solutions are co-designed with clients and delivered incrementally in as little as two weeks.
- Artificial Intelligence
- Data & Analytics
- Drug Discovery & Therapeutics
- Enterprise Software
- Healthcare Technology
- Software Only
Funding
Founders
Product
Problem
Drug development relies on thousands of highly specialized experts whose judgment drives value, yet these professionals are increasingly burdened by data management, documentation, and coordination tasks that consume their time. As portfolios grow and decision cycles shorten, organizations struggle to protect expert bandwidth, leading to delayed programs, paused drug candidates, and slower patient access to effective treatments.
Solution
Edian.ai provides AI-powered decision support tooling designed for highly regulated life sciences environments, enabling expert teams to focus on high-value judgment work. The platform delivers unique tooling that supports fast, accurate decisions and deliverables across sponsor, CRO, and vendor collaboration, clinical trial planning and operations, regulatory intelligence, quality and manufacturing, commercial and market access, and medical affairs. Solutions are co-designed with each organization's workflows and people, then delivered incrementally in as little as two weeks, ensuring easy adoption and measurable results. The system is GxP-aligned and 21 CFR Part 11 compliant, with data safely deployable within the customer's own environment.
Target Audience
Primary customers are pharmaceutical and biotechnology companies, contract research organizations (CROs), and life sciences teams with global impact who need to accelerate clinical development, improve regulatory decision-making, and protect expert time in regulated environments.
Features
- AI-powered decision intelligence that equips decision committees with data-rich go/no-go intelligence for drug candidate programs
- GxP-aligned architecture with 21 CFR Part 11 compliance and deployment options within the customer's own environment for data security
- Co-designed solutions tailored to existing workflows, with incremental production-ready delivery in as little as two weeks
- Support for six functional areas: Sponsor/CRO/Vendor Collaboration, Clinical Trial Planning & Ops, Regulatory Intelligence, Quality & Manufacture, Commercial & Market Access, and Medical Affairs
- Built on a decade of experience deploying AI systems in highly regulated environments with emphasis on transparency, traceability, and human oversight